At a glance
ClinicalIndex Comparison RecordN/ACompleted· 66 enrolled
Drug / intervention
Belotero Balance®device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pilot Study to Assess the Effectiveness and Safety of Belotero Balance® Injection for Volume Augmentation of the Infraorbital Hollow
In Brief
A clinical study evaluating Belotero Balance® for Correction of Volume Loss in the Infraorbital Hollow Area. Completed, enrolled 66 participants across 3 sites.
Detailed Summary
The pilot study aims to define safety, effectiveness, and patient-reported outcomes for Belotero Balance® use in the infraorbital hollows.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedDec 2018
Enrollment StartDec 2018
Primary CompletionJun 2019
Study CompletionMar 2020
TodayJul 2026
First PostedDec 17, 2018
Enrollment StartDec 27, 2018
Primary CompletionJun 18, 2019
Study CompletionMar 11, 2020
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 7.5 years ago
Interventions
Belotero Balance®device
Belotero® Balance for infraorbital hollows. Mode of application: subdermal injection.